Mohammad Rahimi-Gorji , Lotte Desmet , Stéphane Dorbolo , Charlotte Debbaut , Sarah Cosyns , Wouter Willaert , Wim Ceelen
{"title":"Operating characteristics of nebulizers used for intraperitoneal aerosolized drug delivery","authors":"Mohammad Rahimi-Gorji , Lotte Desmet , Stéphane Dorbolo , Charlotte Debbaut , Sarah Cosyns , Wouter Willaert , Wim Ceelen","doi":"10.1016/j.jaerosci.2025.106615","DOIUrl":null,"url":null,"abstract":"<div><div>Intraperitoneal aerosolized drug delivery (IPADD) is a minimally invasive technique for treating peritoneal metastasis (PM), combining laparoscopy with locoregional chemotherapy delivery as an aerosol. This study investigated key operating and physical parameters affecting IPADD performance, focusing on aerosolization pressure, droplet size distribution (DSD), and spray cone angle using six commercialized nebulizers: Nebulizer 770-12 (REGER Medizintechnik), CapnoPen™(CapnoPharm), HurriChem™ (ThermaSolutions), MCR-4 TOPOL™ (Skala), QuattroJet™ (REGER Medizintechnik), and MiniJet (REGER Medizintechnik) in a reconstructed peritoneal cavity model. Results indicated notable variations in nebulizer performance. Nebulizer 770-12, CapnoPen, and HurriChem showed similar technical characteristics and reliable performance. DSD analysis showed bimodal distributions, with MiniJet and HurriChem producing small droplets (10–20 μm), while MCR-4 TOPOL generated larger droplets due to its larger orifice and distinctive design. Spray cone angle measurements demonstrated that higher flow rates slightly improved dispersion, with the MCR-4 TOPOL achieving the widest angles. Optimal flow rates for uniform spray patterns varied, with CapnoPen and HurriChem performing well at lower rates, while MCR-4 TOPOL and QuattroJet required higher flow rates (>1.0 mL/s). This comprehensive evaluation provides valuable insights to optimize nebulizer selection and aerosolized drug delivery for improved IPADD efficacy.</div></div>","PeriodicalId":14880,"journal":{"name":"Journal of Aerosol Science","volume":"188 ","pages":"Article 106615"},"PeriodicalIF":2.9000,"publicationDate":"2025-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Aerosol Science","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0021850225000928","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, CHEMICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Intraperitoneal aerosolized drug delivery (IPADD) is a minimally invasive technique for treating peritoneal metastasis (PM), combining laparoscopy with locoregional chemotherapy delivery as an aerosol. This study investigated key operating and physical parameters affecting IPADD performance, focusing on aerosolization pressure, droplet size distribution (DSD), and spray cone angle using six commercialized nebulizers: Nebulizer 770-12 (REGER Medizintechnik), CapnoPen™(CapnoPharm), HurriChem™ (ThermaSolutions), MCR-4 TOPOL™ (Skala), QuattroJet™ (REGER Medizintechnik), and MiniJet (REGER Medizintechnik) in a reconstructed peritoneal cavity model. Results indicated notable variations in nebulizer performance. Nebulizer 770-12, CapnoPen, and HurriChem showed similar technical characteristics and reliable performance. DSD analysis showed bimodal distributions, with MiniJet and HurriChem producing small droplets (10–20 μm), while MCR-4 TOPOL generated larger droplets due to its larger orifice and distinctive design. Spray cone angle measurements demonstrated that higher flow rates slightly improved dispersion, with the MCR-4 TOPOL achieving the widest angles. Optimal flow rates for uniform spray patterns varied, with CapnoPen and HurriChem performing well at lower rates, while MCR-4 TOPOL and QuattroJet required higher flow rates (>1.0 mL/s). This comprehensive evaluation provides valuable insights to optimize nebulizer selection and aerosolized drug delivery for improved IPADD efficacy.
期刊介绍:
Founded in 1970, the Journal of Aerosol Science considers itself the prime vehicle for the publication of original work as well as reviews related to fundamental and applied aerosol research, as well as aerosol instrumentation. Its content is directed at scientists working in engineering disciplines, as well as physics, chemistry, and environmental sciences.
The editors welcome submissions of papers describing recent experimental, numerical, and theoretical research related to the following topics:
1. Fundamental Aerosol Science.
2. Applied Aerosol Science.
3. Instrumentation & Measurement Methods.